Selecting promising ALS therapies in clinical trials

Neurology. 2007 May 1;68(18):1545-6; author reply 1546. doi: 10.1212/01.wnl.0000265319.46474.f6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Animals
  • Clinical Protocols / standards
  • Clinical Trials as Topic / standards*
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical / methods
  • Drug Evaluation, Preclinical / standards*
  • Humans
  • Mice
  • Mice, Transgenic / genetics
  • Mice, Transgenic / metabolism
  • Neuroprotective Agents / pharmacokinetics
  • Patient Selection

Substances

  • Neuroprotective Agents